World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
10109
World Ranking
3641
National Ranking
1682

Overview

David E. Lanar is a researcher affiliated with the Walter Reed Army Institute of Research in the United States. Their work primarily focuses on topics related to infectious diseases, including malaria and HIV, with a strong emphasis on epidemiology and immunology.

The scientist has contributed to fields of study such as Medicine, Immunology and Microbiology, and Public Health, Environmental, and Occupational Health. Their subfields of specialization include Virology along with public health aspects related to disease control.

David E. Lanar's main research topics cover Malaria Research and Control, HIV Research and Treatment, and Mosquito-borne Diseases and Control. These areas reflect a focus on the study and management of pathogens that have a significant impact on global health.

Their recent publication record includes the following paper:

  • First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults, 2022, Vaccine

David E. Lanar frequently collaborates with several co-authors, including:

  • Jack Hutter
  • Paul M. Robben
  • Christine Lee
  • Melinda Hamer
  • James E. Moon

Their work has been featured in the journal Vaccine, marking the publication venue associated with their contributions.

Best Publications

  • Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria

    Faith H. A. Osier;Faith H. A. Osier;Gregory Fegan;Gregory Fegan;Spencer D. Polley;Linda Murungi

  • A field trial to assess a blood-Stage malaria vaccine

    Mahamadou A. Thera;Ogobara K. Doumbo;Drissa Coulibaly;Matthew B. Laurens

  • Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax

    Ronald Rosenberg;Robert A. Wirtz;David E. Lanar;Jetsumon Sattabongkot

  • Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.

    E J Pearce;S L James;S Hieny;D E Lanar

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Long-Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

    J A Stoute;K E Kester;U Krzych;B T Wellde

  • Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria

    Spencer D. Polley;Tabitha Mwangi;Clemens H.M. Kocken;Alan W. Thomas

  • Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

    D. Gray Heppner;Kent E. Kester;Christian F. Ockenhouse;Nadia Tornieporth

  • Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

    Michele D. Spring;James F. Cummings;Christian F. Ockenhouse;Sheetij Dutta

  • IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

    Samson M Kinyanjui;David J Conway;David E Lanar;Kevin Marsh

  • Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice.

    David E. Lanar;Edward J. Pearce;Stephanie L. James;Alan Sher

  • Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific.

    Onome J. Akpogheneta;Onome J. Akpogheneta;Nancy O. Duah;Nancy O. Duah;Kevin K. A. Tetteh;Samuel Dunyo

  • Update on the clinical development of candidate malaria vaccines

    W. Ripley Ballou;Myriam Arevalo-Herrera;Daniel Carucci;Thomas L. Richie

  • NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

    J. A. Tine;D. E. Lanar;D. M. Smith;B. T. Wellde

  • A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria

    Stephen Abanega Kaba;Clara Brando;Qin Guo;Christian Mittelholzer

  • A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

    Alison Roth;Steven P. Maher;Steven P. Maher;Amy J. Conway;Ratawan Ubalee

  • Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

    Chandy C. John;Ann M. Moormann;Daniel C. Pregibon;Peter Odada Sumba

  • Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

    Mahamadou A. Thera;Ogobara K. Doumbo;Drissa Coulibaly;Dapa A. Diallo

  • Structural basis of antigenic escape of a malaria vaccine candidate

    Sheetij Dutta;Seung Yeon Lee;Adrian H. Batchelor;David E. Lanar

  • Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites

    Sheetij Dutta;J. David Haynes;J. Kathleen Moch;Arnoldo Barbosa

Frequent Co-Authors

D. Gray Heppner
D. Gray Heppner Crozet BioPharma
Kevin C. Kain
Kevin C. Kain University Health Network
Joe Cohen
Joe Cohen GlaxoSmithKline (United Kingdom)
W. Ripley Ballou
W. Ripley Ballou International AIDS Vaccine Initiative
Christian F. Ockenhouse
Christian F. Ockenhouse Walter Reed Army Institute of Research
Urszula Krzych
Urszula Krzych United States Army Research Laboratory
David L. Narum
David L. Narum National Institutes of Health
Kent E. Kester
Kent E. Kester Walter Reed Army Institute of Research
Christopher V. Plowe
Christopher V. Plowe University of Maryland, Baltimore
David J. Conway
David J. Conway London School of Hygiene & Tropical Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open multiple career pathways. Accelerated nursing programs can serve as a strong foundation, and the easiest ABSN programs to get into provide a fast track for students looking to advance quickly into clinical roles.

Another practical route in healthcare is becoming a licensed practical nurse (LPN). Many students prefer the fastest and easiest LPN programs, which allow entry into nursing care with relatively short program durations and flexible online options.

For those aiming higher in clinical practice, nurse practitioner degrees offer expanded responsibilities and autonomy. Identifying easy nurse practitioner programs to get into can help aspiring professionals embark on this career with less admission stress and comprehensive training.

Mental health focus within nursing is growing fast, and many students are drawn to psychiatric-mental health nurse practitioner (PMHNP) programs. The top online PMHNP programs are known for their excellent clinical placement rates, allowing students to gain vital hands-on experience while completing their degrees remotely.

Best Scientists Citing David E. Lanar

Trending Scientists